abstract |
The present invention provides mutant actin IIB soluble receptor polypeptides and proteins that can bind to actin A, myostatin or GDF-11 to inhibit its activity. The present invention also provides polynucleotides, vectors and host cells capable of producing mutant polypeptides and proteins. Also provided are compositions and methods for treating muscle wasting and other diseases and disorders. |